Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon

Recaps

I Can Extract Side Effects
VolumesArcsSummaries

Arc 10Sanqing’s Expanding Reach

Sanqing Pharmaceutical’s fast-acting locust pesticide brought the company international attention, while its medicines helped patients and its gene-editing work advanced in healthcare and agriculture. The arc ended with high-yield Super Soybeans and other improved crops entering wider trials.

  • Chinese agricultural officials tested Sanqing’s low-toxicity pesticide, and Xia Lizhi used it to kill locusts in Pakistan within minutes.
  • Ethiopian officials chose Three Purities’ insecticide after seeing its success, and countries across the affected regions placed large orders through Syngenta.
  • Sun Chengren and Gu Xian negotiated medicine sales in Africa, while Salman brought Thalassemia patients to China and Sanqing began developing a tailored Gene Drug.
  • Wang De and Three Purities formed a partnership to develop gene-edited crops, producing soybean samples that Syngenta planted for trials.
  • Sanqing’s experimental cardiovascular drugs helped Song Zhi Xing recover from paralysis, and his reunion with wartime comrades followed.
  • Sanqing developed a Thalassemia Gene Drug that restored Salman’s health, then launched a charity foundation to fund treatment trials for other patients.
  • Brother Jiazhen exposed weaknesses in other fundraising platforms and showed that Sanqing’s Longtu APP checked applicants’ eligibility before approving aid.
  • Wang De’s team measured Super Soybean yields above 1,000 jin per mu for one variety and prepared wider trials of the soybeans and other improved crops.
Chapters 226–250 Vol. 3 Read

Ch. 226Global Locust Plague

News reports of an unprecedented locust plague spreading from Feizhou across Africa and toward Asia sparked alarm and debate. Experts worldwide gathered to discuss how to contain the swarms, while the chapter left the disaster unresolved.

  • CCTV reported that vast Desert Locust swarms had devastated Feizhou and spread across East Africa, the Desert Peninsula, and neighboring regions, threatening crops and food security.
  • Chinese viewers shared the footage and argued that the locusts could be eaten or fed to poultry, while others explained that such methods could not handle swarms of this scale.
  • Netizens debated pesticide use, noting that stronger chemicals could harm beneficial insects, birds, and the environment, and that locusts could develop resistance.
  • Biological, agricultural, and pesticide experts from around the world gathered to discuss how to address the spreading locust disaster.
Read chapter

Ch. 227Do the Three Purities Have Pesticides Too?

Chinese officials prepared for the spreading locust disaster as an agricultural official learned that Sanqing Pharmaceutical had developed a promising new pesticide. He ordered the Academy of Agricultural Sciences to test its effectiveness against locusts, leaving the company’s potential role in the response unconfirmed.

  • A task force reported that Desert Locusts in Pakistan had entered their breeding period, and Chinese experts assessed the risk of them reaching border provinces.
  • Agricultural officials agreed to strengthen locust monitoring and preparedness, including stockpiling pesticides and improving emergency plans.
  • The official’s secretary reported that Sanqing Pharmaceutical had developed a low-toxicity pesticide that performed exceptionally well in initial tests.
  • The official ordered the Academy of Agricultural Sciences to test the pesticide against locusts and said he would report its significance if the results proved remarkable.
  • As the plague spread internationally, chemical and pharmaceutical companies announced plans to help develop locust-control products.
Read chapter

Ch. 228Each Displays Their Divine Abilities

As locusts devastated crops across several regions, pharmaceutical companies raced to develop pesticides, but their solutions proved too slow or raised unanswered concerns. India claimed to have eliminated the swarm, then Persia revealed the locusts had merely turned toward its territory, and the chapter ended with an agricultural expert announcing that Chinese ducks would be sent abroad to fight them.

  • Roche announced a fungus that killed locusts but acted too slowly to stop the fast-moving swarms, while Bayer promoted a chemical insecticide without providing enough information about its dangers.
  • The locusts ravaged crops and tourism, and India declared that it had eliminated the approaching swarm after deploying drones and troops.
  • Persia revealed that most locusts had turned away from India toward southern Persia, warning India to watch for returning swarms and eggs near its borders.
  • Chinese netizens worried about the plague reaching China and discussed the country’s ability to respond.
  • An agricultural expert announced that Chinese Ducks would head abroad to eliminate locusts.
Read chapter

Ch. 229Divine-Grade Insecticide

A viral interview promoted a 100,000-duck army as China’s answer to Pakistan’s locust plague, while the agricultural work team faced the devastation firsthand. Xia Lizhi tested a mysterious new insecticide and watched it kill swarms of locusts within minutes, leaving the team stunned by its apparent effectiveness.

  • A professor’s interview about sending 100,000 ducks to fight locusts went viral, drawing mockery and cautious hope from netizens.
  • Xia Lizhi observed the locust swarm ravaging Punjab Province after Pakistan’s efforts to control it had failed.
  • Fang Yu brought Xia Lizhi a batch of new insecticide and urged him to test it.
  • Xia Lizhi sprayed the locusts, and they began falling dead from the sky within minutes.
  • Xia Lizhi and the team emptied their spray bottles across the area, clearing the sky and piling the ground with locust corpses.
Read chapter

Ch. 230A Lion's Mouth

Global agrochemical giants offered African nations expensive or limited anti-locust pesticides, prompting Jemol to seek alternatives. Syngenta directed the African Union toward China's Three Purities, whose new pesticide had reportedly worked well in Pakistan.

  • DuPont, Bayer, and BASF executives promoted their new anti-locust pesticides while refusing to offer them for free.
  • At negotiations in Ethiopia, Jemol rejected DuPont's high price, questioned Bayer's pesticide safety, and learned BASF could supply only three thousand tons.
  • Robert urged African nations to borrow from Western bankers to fund purchases, while Jemol recognized the companies' alliance and postponed a decision.
  • Jemol and the other representatives decided to contact Syngenta and compare suppliers before placing orders.
  • Syngenta offered older pesticides at low prices but referred the African Union to China's Ministry of Agriculture and Three Purities' tested locust-control pesticide.
  • Jemol wondered whether Three Purities, which he knew as a pharmaceutical company, also produced pesticides.
Read chapter

Ch. 231Nations Exterminate Locusts, Comparing Medicine Efficacy

DuPont, Bayer, and BASF pursued locust-control contracts in several countries, while Sanqing Pharmaceutical’s insecticide impressed African officials with its rapid results. DuPont’s pesticide failed to stop Dubai’s locusts immediately, leaving Crown Prince Mohammed furious as Robert explained that it would take five days to work.

  • Crown Prince Mohammed ordered 1,000 tons of DuPont and Roche’s environmentally friendly biopesticide for Dubai, and Robert stayed to arrange aerial spraying.
  • India’s President ordered 1,000 tons of Bayer’s pesticide, while BASF’s chief executive failed to secure any contracts during his sales trip.
  • BASF’s chief executive returned to Ethiopia and learned from Jemol that African officials had ordered Sanqing Pharmaceutical’s insecticide instead.
  • Jemol showed BASF’s chief executive a video of Sanqing’s insecticide wiping out a locust swarm in Pakistan, shocking him into fearing BASF’s pesticide would go unsold.
  • Mohammed and Robert watched DuPont’s pesticide sprayed over Dubai, but the locusts kept devouring vegetation for hours.
  • Mohammed challenged Robert about the pesticide’s failure to act, and Robert explained that it would take five days to begin killing locusts.
Read chapter

Ch. 232Shocking Medicinal Effects

India’s trial of Bayer’s pesticide raised alarms when its chemical fumes made the President ill, while Ethiopia’s use of Three Purities’ pesticide rapidly wiped out locusts. By the next morning, Jemol found the treated fields covered in dead locusts and no swarms remaining.

  • India’s President and Bayer’s chief executive watched Bayer’s pesticide kill some locusts, but experts worried about its strong odor and possible toxicity.
  • India’s experts began testing the air and dead locusts as the swarm’s death rate slowed and the President questioned Bayer’s effectiveness.
  • The President of India inhaled the fumes, vomited, and nearly collapsed, prompting officials to suspect Bayer’s pesticide was dangerously toxic.
  • Jemol arranged for planes to spray Three Purities’ pesticide over Ethiopia’s locust swarms, which began falling dead after about ten minutes.
  • Jemol collected dead locusts for toxicology testing, then returned to the fields the next morning and found the plague seemingly wiped out.
Read chapter

Ch. 233No Comparison, No Harm

After DuPont and Bayer's pesticides failed or caused environmental harm, Ethiopia and Pakistan eradicated their locust plagues with Three Purities' fast, low-toxicity insecticide. Demand surged worldwide, and Three Purities partnered with Syngenta to fill the flood of orders while India struggled to secure a supply.

  • Netizens criticized DuPont's slow-acting pesticide and condemned Bayer's pesticide for poisoning people and damaging the environment.
  • Ethiopia and Pakistan announced that Three Purities' insecticide had swiftly eradicated their locust swarms with a kill rate above 99%.
  • Countries across Feizhou, Persia, and the Desert Peninsula ordered Three Purities' insecticide, while India was left waiting and its president sought priority supply at a higher price.
  • Three Purities received orders totaling tens of thousands of tons and arranged for Syngenta to manufacture the insecticide and ship it to affected countries.
Read chapter

Ch. 234A Small $6 Billion Windfall

Sanqing earned about six billion dollars from pesticide orders during the locust plague, then planned to expand its pharmaceutical presence overseas while keeping agricultural chemicals as a side business. DuPont and Bayer assessed the threat Sanqing posed after its insecticide successes, leaving the industry braced for tougher competition.

  • Sun Chengren reported that Sanqing had signed pesticide contracts with twenty-five countries worth approximately six billion dollars, and Wei Kang said the company would keep its focus on pharmaceuticals while cooperating with manufacturers such as Syngenta.
  • Wei Kang told Sun Chengren that African Union countries and other nations wanted to import Sanqing medicines, and he outlined a strategy of selling both expensive original drugs and affordable generics overseas.
  • DuPont’s directors confronted CEO Robert over the failure of their insecticide, while a Roche director withdrew from their proposed agricultural partnership and wrote off Roche’s earlier investment.
  • Bayer executives acknowledged Sanqing’s strength in insecticides and animal medicine, then agreed to avoid direct competition and defend niche markets through product improvements.
Read chapter

Ch. 235Feizhou Seeks Medical Cooperation

Sanqing representatives met with African Union officials in Ethiopia to discuss introducing the company’s original and generic medicines to Feizhou. They agreed on prices for the original drugs and reviewed generic drug needs, while Gu Xian considered outsourcing production to meet demand.

  • Sanqing’s success in supplying pesticides made its name widely known across Feizhou and prompted African officials to seek its medicines.
  • Jemol welcomed Sun Chengren, Gu Xian, and the Sanqing team to the African Union headquarters in Ethiopia to discuss market expansion.
  • An Ethiopian health official asked about Sanqing’s drugs and a Gene Drug for Sickle Cell Anemia, and Sun Chengren said its development was underway.
  • Sun Chengren negotiated prices for Sanqing’s original drugs, keeping price reductions modest while emphasizing future Gene Drugs.
  • Gu Xian recorded the requested generic drugs and considered using domestic contract manufacturers to supply Feizhou’s large market.
Read chapter

Ch. 236Desert Tycoons Flock to China for Medical Treatment

Salman and other wealthy patients from Desert Country traveled to China seeking treatment from Sanqing Pharmaceutical, prompting the company to begin developing a Gene Drug for Thalassemia. As Salman awaited treatment in Kun City, news of the delegation and Sanqing’s successes sparked widespread public excitement.

  • Salman learned that Sanqing Pharmaceutical could develop a Gene Drug to treat his worsening Thalassemia and asked Crown Prince Mohammed to arrange a meeting.
  • At a Dubai banquet, Sun Chengren promised Salman that Sanqing would develop a treatment, and Salman offered to fund the research and travel to China.
  • Salman chartered a plane to bring Sun Chengren, Gu Xian, and a group of wealthy Desert Country patients to China for treatment.
  • Wei Kang approved Salman’s request, and Sanqing’s Gene Laboratory began an all-out effort to develop a Gene Drug for Thalassemia.
  • Salman settled into Kun City’s Hilton Hotel while the other patients received care at Kun City First People’s Hospital and explored Sanqing’s products.
  • Chinese media reported on the patients’ arrival and Sanqing’s achievements, prompting enthusiastic reactions from netizens.
Read chapter

Ch. 237Syngenta's Seed Industry Comeback Battle

Syngenta President Wang De pursued a partnership with Three Purities to use gene editing to develop high-yield crops. After the companies agreed to cooperate, their teams rapidly created gene-edited soybean samples and planted them for trials, leaving their performance unknown.

  • Wang De decided Syngenta should work with Three Purities on gene-edited crops and called Sun Chengren to propose a partnership.
  • Sun Chengren reported the proposal to Wei Kang, who approved a cross-industry strategic partnership.
  • Wang De and the Syngenta seed team traveled to Kun City, signed an agreement with Three Purities, and formed a joint project team focused first on soybeans.
  • The project team targeted the “Sweet 10” and “Sweet 15” genes, and Three Purities' biologists developed edited soybean seed samples in two weeks.
  • Wang De brought the samples to Syngenta's Lu Province base, where staff planted them in a rapid-breeding facility for trials.
Read chapter

Ch. 238Generic Drug Factory

Huang Qin and Liu Dan presented Sanqing’s gene-edited crop results and the commercial promise of the new seeds. Meanwhile, Sanqing arranged to outsource generic-drug production to Divine Land Pharmaceutical, giving Xie Wei a path out of the company’s financial crisis and leaving him ready to negotiate better raw-material prices.

  • Huang Qin reported that Sanqing’s insect-resistant corn and insect- and drought-resistant rice had achieved strong results, and he outlined further research into improving rice quality.
  • Liu Dan praised the joint team’s work and described the potential economic benefits of widely adopting the new seeds.
  • Xie Wei received notices of steep raw-material price increases, which threatened Divine Land Pharmaceutical after it had accepted low-price centralized procurement bids.
  • After learning Sanqing was seeking generic-drug contract manufacturers, Xie Wei eagerly prepared for an inspection and hoped the partnership could help transform his company.
  • Gu Xian and Zhao Xiaojie inspected Divine Land, approved its facilities and pricing, and agreed to begin trial production and six months of stability testing before granting formal approval.
  • With Sanqing’s potential orders in view, Xie Wei resolved to negotiate more favorable prices with the API companies.
Read chapter

Ch. 239Willow Catkins Battle Phoenix Tree Catkins, Who's More Powerful?

Shu Xin, who suffered from severe seasonal allergic rhinitis, joined a clinical trial for Three Purities' new long-acting allergy medicine and found that it quickly stopped her symptoms. She learned the medicine only blocked her allergic reaction, but hoped to use it after the trial once it reached the market.

  • Shu Xin struggled with worsening allergic rhinitis as willow and poplar fluff filled Capital City and read online complaints about drifting catkins.
  • Three Purities announced a Phase III trial for a new allergy drug, and Shu Xin registered and booked an appointment at a partner hospital.
  • After a doctor confirmed her condition and gave her one sustained-release pill, Shu Xin's congestion, itching, and sneezing stopped within minutes.
  • Shu Xin slept well and remained symptom-free for a week, then returned to the hospital and learned the medicine had only suppressed her allergy temporarily.
  • Shu Xin asked the doctor from Ning City whether plane tree catkins or willow catkins were worse, and he advised her to avoid drifting catkins altogether.
Read chapter

Ch. 240Netizens Demand Answers, Blaming the Three Purities for Being Too Low-Key?

Shu Xin’s praise of Three Purities’ allergy medicine sparked a viral discussion about the company’s lesser-known products, including a hemostatic spray and depilatory cream. After netizens blamed Three Purities’ marketing team for failing to advertise its medicines, Wei Kang promised to announce future releases widely and learned that three new cardiovascular drugs had entered Phase III trials.

  • Shu Xin posted about how Three Purities’ anti-allergy medicine relieved her rhinitis, and other clinical trial participants and patients praised the company’s everyday medicines.
  • Boundless Desert shared a video showing Three Purities’ hemostatic spray quickly stopping a soldier’s bleeding, prompting netizens to ask how they could get it.
  • Netizens searched Three Purities’ website, found depilatory cream and other products, and flooded Wei Kang’s homepage with complaints about the company’s lack of advertising.
  • Wei Kang had the operations team promise to publicize every future drug release, calming the online uproar.
  • Wei Kang received news that Three Purities’ three new cardiovascular disease drugs had entered Phase III clinical trials.
Read chapter

Ch. 241Hero's Brain Infarction Paralysis, Who Can Save Him?

Three Purities sent its new cardiovascular drugs to help a ninety-year-old war hero suffering from cerebral infarction, after Wei Kang agreed to support his treatment. When Du Cheng sang the Volunteers' battle song at the hospital, the old man responded to the familiar melody by raising his hand and moving his fingers.

  • Three Purities announced its new antihypertensive, anticoagulant, and anti-thrombotic drugs, prompting Du Cheng to ask Wei Kang whether they could help a paralyzed veteran.
  • Wei Kang agreed to provide the clinical trial reports and do what he could for the ninety-year-old hero, who had earned two First-Class Merit Citations and two Second-Class Merit Citations.
  • Du Cheng brought samples of the three drugs and their trial reports to the hospital, where Director Fang judged the results promising enough to try.
  • Du Cheng visited the veteran's ward and sang the Volunteers' battle song, which the old man recognized as he raised his hand and moved his fingers to the rhythm.
Read chapter

Ch. 242Treat a dead horse as if it were alive

Du Cheng and Director Fang saw Song Zhi Xing begin recovering after five days on Sanqing Pharmaceutical’s trial drug, and the old soldier responded to his unit numbers with a salute and the word “Present.” The sight of Du Cheng’s uniform stirred Song Zhi Xing’s memories of the brutal battle where he had lost his comrades.

  • Du Cheng recalled Song Zhi Xing’s concealed wartime service and vowed to do everything he could to help cure him.
  • Song Zhi Xing’s family agreed to try Sanqing Pharmaceutical’s experimental drugs after Director Fang warned them about the risks.
  • After five days of treatment, Director Fang found no adverse reactions and saw signs of improvement on Song Zhi Xing’s CT scan.
  • When Director Fang said Song Zhi Xing’s unit numbers, Song Zhi Xing saluted and managed to say, “Present.”
  • Du Cheng saluted Song Zhi Xing, whose response to the military uniform brought back memories of freezing conditions, grievous wounds, and comrades lost in battle.
Read chapter

Ch. 243A Miracle Occurs, Complete Recovery

Old Song’s condition improved dramatically with medication and rehabilitation, allowing him to walk again after a month. He reunited with three surviving comrades from his regiment, and the old soldiers clasped hands after decades apart.

  • Director Fang reported that Old Song was conscious and stable, and outlined his treatment and rehabilitation plan.
  • Du Cheng visited Old Song, who recalled his wartime service after hearing that military leaders and former comrades would visit him.
  • After a week of medication, Director Fang found that Old Song’s paralysis had improved to hemiplegia and arranged rehabilitation training.
  • Old Song’s family helped with his exercises, and a month later he was walking with their support.
  • Du Cheng and Director Fang were astonished by Old Song’s recovery as three elderly comrades arrived to see him.
  • Old Song recognized the three men, and the four surviving comrades reunited after half a century apart.
Read chapter

Ch. 244Aftershocks

News of Old Song’s recovery spread nationwide, drawing patients to 301 Hospital and prompting Director Gao to seek access to Sanqing’s drugs. After reviewing the clinical trial report, Wang Guiqing decided to support expanding the medicines’ Phase III trials to speed approval while verifying their safety.

  • Media reports celebrated Old Song’s recovery and his wartime service, and viewers identified 301 Hospital as the place that had treated him.
  • Patients with cerebral thrombosis and their families flocked to 301 Hospital after learning of Old Song’s recovery.
  • Director Fang told Director Gao that Sanqing’s three cardiovascular and cerebrovascular drugs had restored Old Song’s health in a month.
  • Director Gao reviewed Old Song’s records and left to seek a clinical partnership with Sanqing.
  • Wang Guiqing read Sanqing’s clinical trial report and decided to help expand Phase III trials for the medicines.
Read chapter

Ch. 245The Antidote for Thalassemia

Prince Salman received Gene Drug treatment from Sanqing and was told his Thalassemia had been cured, prompting news of the cure to spread across the Desert Peninsula and China. The chapter ends with actor Chen Yong seeing the announcement and realizing he and his wife might be able to have a child without fearing the disease.

  • Prince Salman learned that Sanqing had developed a Gene Drug tailored to his mutated gene and underwent treatment at a partner hospital.
  • Prince Salman felt stronger after treatment, resumed swimming and eating freely, and later learned his hemoglobin had returned to normal.
  • Prince Salman returned to Desert Country, where Crown Prince Mohammed publicized his recovery and news of the cure spread among people with Thalassemia.
  • Three Purities announced its successful Thalassemia Gene Drug, drawing attention from Chinese patients and carriers.
  • Chen Yong saw the announcement and told his wife that there was hope for his illness and their plans to have a child.
Read chapter

Ch. 246Charity Foundation, The Threshold for Global Rich People to See a Doctor

Wei Kang and Three Purities established the Sanqing Charity Foundation to fund Thalassemia Gene Drug trials, requiring wealthy applicants to donate for clinical-trial priority. The chapter left Solomon paying more and more to climb the waiting list, only to find himself back in last place after a month.

  • Wei Kang and Chen Yiqing, Wenren Long, and Tang Que discussed the limited capacity for customized Thalassemia treatments and agreed to establish a charity foundation funded by wealthy patients seeking trial slots.
  • Three Purities launched the Sanqing Charity Foundation, announced Prince Salman's ten-million-dollar donation, and began ranking applicants by their contributions.
  • A Camel Country tycoon donated ten million dollars and rose into the top three on the clinical-trial waiting list.
  • Solomon initially objected to the one-million-dollar entry donation, then contributed more after learning that an acquaintance had secured a trial slot by donating eight million dollars.
  • Solomon raised his donation to five million dollars and reached the top fifty, but after waiting a month, he found he had fallen back to last place.
Read chapter

Ch. 247Who's Best at Robbing the Rich to Aid the Poor

Three Purities raised five billion yuan to fund Thalassemia trials, prioritizing severely ill children and giving wealthy donors earlier access through donations. After patients began recovering, a report criticizing the foundation drew public backlash, and people began exploring its transparent charity records and donation portal.

  • Three Purities raised five billion yuan in donations and began a 500-slot Thalassemia trial, reserving most remaining slots for severely ill patients, especially children.
  • After customized Gene Drugs were produced, patients received gene-edited bone marrow transplants, and many showed strong recovery after a week.
  • Chen Yong described donating three million yuan for a trial slot and defended Sanqing’s free treatment for poor children when a reporter challenged the donation system.
  • A report accused Sanqing of coercing patients into donations, but netizens defended the foundation and criticized the article.
  • People examined Sanqing Charity Foundation’s public records, and one user discovered that ordinary people could donate through its website.
Read chapter

Ch. 248How the Three Purities Do Charity

Brother Jiazhen exposed a woman who faked a medical fundraiser and demonstrated how easily fraudulent appeals passed review on several platforms. He contrasted those failures with the strict checks on Sanqing’s Longtu APP, leaving viewers more confident in Sanqing and prompting donations to its charity foundation.

  • Brother Jiazhen showed viewers a fundraiser claiming a woman’s father had stomach cancer, then found her Langbo posts flaunting luxury shopping and travel.
  • Brother Jiazhen revealed that he had tested Shuidichou, Aixinchou, and Qingsongchou with fake medical documents and successfully launched and withdrew funds.
  • Brother Jiazhen described how Sanqing’s Longtu APP rejected his fundraising applications after checking his documents, assets, income, and eligibility.
  • Viewers praised Sanqing’s strict review process, and Brother Jiazhen’s investigation spread online and inspired netizens to donate to the Sanqing Charity Foundation.
Read chapter

Ch. 249Super Soybean Yielding a Thousand Jin Per Mu

At Syngenta's Lu Province agricultural base, Wang De and the seed team harvested three gene-edited soybean varieties, and GD001 yielded more than 1,000 jin per mu, breaking the domestic record. The results raised hopes of reducing China's dependence on imported soybeans, and Wang De celebrated the prospect of eventual self-sufficiency.

  • Wang De ordered the soybean harvest in the rapid-breeding plant workshop.
  • An expert weighed GD001 and calculated its yield at 517 kilograms per mu, equivalent to more than 1,000 jin per mu.
  • The team weighed the other two varieties, finding that one yielded more than 800 jin per mu and the other more than 900.
  • Wang De considered how the high yields could help close China's soybean production shortfall and laughed with the team.
Read chapter

Ch. 250The Boom of Genetically Modified Crops

Wang De sent experts to test Super Soybeans in varied regions to determine their real-world yields and address the challenges of scaling up cultivation. Meanwhile, experts inspected Three Purities’ other gene-edited crops, whose successful trials could lead to a broad wave of new varieties reaching the market.

  • Wang De arranged for soybean experts to plant Super Soybeans in test fields across China, including bases in Heilongjiang, Xinjiang, and the Yellow River-Huai River-Hai River region.
  • The experts estimated that Super Soybeans could yield over 800 jin per mu in high-yield regions and around 500 jin per mu elsewhere, pending trial results.
  • After the soybean experts left, the remaining experts inspected genetically modified crops growing in the planting facility.
  • The experts saw peanuts resistant to aflatoxin, non-toxic potatoes, and other improved rice, corn, and vegetables developed with Three Purities’ agricultural division.
  • The chapter described Gene Editing Technology as a way to create improved crops without introducing foreign genes, and noted that the new varieties could reach the market if their trials succeeded.
Read chapter
Arc 10 of 27
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS